re: Ann: Neuren appoints Joe Horrigan VP Clin... A pretty impressive appointment because it strengthens Neus chances of securing further non-dilutionary funding through competative grant funding sources.
This is because Horrigan as a grant funder in his own right knows what makes for an attractive funding application.
Or if you are more cynical - given his clout in terms of controlling the purse strings around one major funding area and his editorial roles in the best journals - means he will get a bit of an easier run through peer review.
Either way - its a very good move by Neu in terms of attracting further funding to progress its work imo.
re: Ann: Neuren appoints Joe Horrigan VP Clin... A pretty...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.090(0.46%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.55 | $19.65 | $18.88 | $10.53M | 549.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4552 | $19.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.30 | 674 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |